Shumei
Shumei Fujita, Aichi Prefecture JP
Patent application number | Description | Published |
---|---|---|
20130264347 | THERMAL INSULATING STRUCTURE OF FUEL TANK FOR MOTOR VEHICLE - A thermal insulating structure of a fuel tank for a motor vehicle, which is readily produced and attached without using any protector for a thermal insulating member. In the thermal insulating structure of the fuel tank mounted under a floor panel of the motor vehicle, at least an entire side surface and an entire bottom surface of the fuel tank are covered with a thermal insulating member that is formed previously. The thermal insulating member includes a foamed layer on an interior side thereof, and an outer layer made of a solid material. The thermal insulating member is attached to the floor panel along with the fuel tank by means of a tank attaching member. | 10-10-2013 |
Shumei Ishihara, Tainai-Shi JP
Patent application number | Description | Published |
---|---|---|
20150202123 | DENTAL CURABLE COMPOSITION, AND METHOD FOR PRODUCING SAME - A dental curable composition containing fluoroaluminosilicate glass particles (A), basic calcium phosphate particles (B1), acidic calcium phosphate particles (B2), a polyalkenic acid (C), tartaric acid (D), and water (E), wherein the dental curable composition contains 70 to 99 parts by weight of (A), 1 to 30 parts by weight in total of (B1) and (B2), 10 to 40 parts by weight of (C), 0.3 to 10 parts by weight of (D), and 10 to 90 parts by weight of (E) each relative to 100 parts by weight in total of (A), (B1), and (B2), and a Ca/P ratio of a sum of (B1) and (B2) is from 1.10 to 1.95. Accordingly, provided is a dental curable composition that is high in mechanical strength, particularly compressive strength, and excellent in remineralization capability. | 07-23-2015 |
Shumei Ishihara, Okayama JP
Patent application number | Description | Published |
---|---|---|
20120027829 | DENTIN MINERALIZING AGENT AND METHOD FOR PRODUCTION THEREOF - A dentin mineralizing agent comprising tetracalcium phosphate particles (A) and an alkali metal salt of phosphoric acid (B), wherein the dentin mineralizing agent contains the tetracalcium phosphate particles (A) in an amount of 1 to 80 parts by weight relative to 100 parts by weight of the whole amount of the dentin mineralizing agent, and the blended amount of the alkali metal salt of phosphoric acid (B) relative to 100 parts by weight of the tetracalcium phosphate particles (A) is 1 to 100 parts by weight. Thus is provided a dentin mineralizing agent by which a dense HAp is formed on a dentin surface and HAp is deposited to a deep portion of a dentinal tubule, so that it can close the dentinal tubule. | 02-02-2012 |
Shumei Ishihara, Kurashiki-Shi JP
Patent application number | Description | Published |
---|---|---|
20130189337 | DENTINAL TUBULE SEALANT AND METHOD FOR PRODUCING THE SAME - A dentinal tubule sealant comprises poorly-soluble calcium phosphate particles (A), a phosphorus-free calcium compound (B), and water (C), wherein the particles (A) are at least one member selected from the group consisting of dicalcium phosphate anhydrous [CaHPO | 07-25-2013 |
20130251767 | METHOD FOR INHIBITING DENTINAL HYPERSENSITIVITY - A method for inhibiting dentinal hypersensitivity by applying a dentinal hypersensitivity inhibitor on a dentin surface. The dentinal hypersensitivity inhibitor contains at least one tetracalcium phosphate particle, an alkali metal salt of phosphoric acid, and at least one acidic calcium phosphate particle. The tetracalcium phosphate particle has an average particle diameter of 0.5 to 40 μm. The dentinal hypersensitivity inhibitor contains a blended amount of the tetracalcium phosphate particle of 5 to 55 parts by weight relative to 100 parts by weight of a whole amount of the dentinal hypersensitivity inhibitor and a blended amount of the alkali metal salt of phosphoric acid of 1 to 100 parts by weight relative to 100 parts by weight of the tetracalcium phosphate particle. | 09-26-2013 |
20130266915 | DENTAL TREATMENT METHOD - Dentinal tubules sealing method using dentinal tubules sealant that is to be applied to a dentin surface to fill solid particles into dentinal tubules, wherein the dentinal tubules sealant comprises a water-based dispersing agent in which solid particles are dispersed and which has a solid/liquid ratio of from 0.3 to 2.6, and the method comprises applying the dentinal tubules sealant to a dentin surface to fill solid particles into dentinal tubules, and then removing a solid component adhering to the dentin surface by scrubbing using water. Thus, pains, hyperesthesia, and so on are allowed to be suppressed because dentinal tubules will be filled and sealed with solid particles and a curable composition is allowed to exhibit improved adhesive properties to a dentin surface because solid components adhering to the dentin surface can be removed by scrubbing using water. | 10-10-2013 |
Shumei Mori, Ichinomiya-Shi JP
Patent application number | Description | Published |
---|---|---|
20140085366 | PRINTER AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM STORING PRINTER CONTROL PROGRAM - A printer includes a plurality of discharge control devices, a control data output device, a connection device, a connection control device, a processor and a memory. The processor performs starting output of specified print data, which is used to discharge the liquid by the discharge port group, from the control data output device to a specified discharge control device which is one of the plurality of discharge control devices that are each connected to one of the plurality of second connection ports and which is a target to perform processing that outputs print data, outputting subsequent print data, which relates is to a specified discharge target onto which the liquid is to be discharged by the discharge port group, to the specified discharge control device that is connected to the second connection port, based on the specified print data for which output has been started. | 03-27-2014 |
20140085367 | PRINTER AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM STORING PRINTER CONTROL PROGRAM - A printer includes discharge control devices, a first ID storage device, a control data output device, a connection device, a connection control device, an assigning device, a processor, and a memory. The processor performs outputting print data, which is data to discharge the liquid by the discharge port group connected to the discharge control device, corresponding to the unique ID from the control data output device, by using a communication ID that corresponds to the unique ID, via a connection device controlled by a connection control device, to each of a plurality of discharge control devices, and controlling discharge of the liquid by the discharge port groups to which the plurality of discharge control devices are respectively connected, in accordance with the print data which corresponds to the unique ID of the individual discharge control device and which has been output from the control data output device. | 03-27-2014 |
Shumei Mori, Ichinomiya JP
Patent application number | Description | Published |
---|---|---|
20090102869 | Printing device, control method thereof and computer-readable recording medium - A printing device comprises first and second print heads, first and second print head control units, a first print head feeding unit moving the first print head in a main scanning direction, a second print head feeding unit moving the second print head in the main scanning direction, a first medium feeding unit moving a first medium holding unit in an auxiliary scanning direction orthogonal to the main scanning direction, a second medium feeding unit moving a second medium holding unit in the auxiliary scanning direction in parallel with the movement of the first medium feeding unit, a first printing unit control unit (controlling the first print head control unit, the first print head feeding unit and the first medium feeding unit), and a second printing unit control unit (controlling the second print head control unit, the second print head feeding unit and the second medium feeding unit). | 04-23-2009 |
Shumei Wang, South San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20110105464 | PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE - Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed. | 05-05-2011 |
20110112085 | THIAZOLOPYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE - Compounds of Formulas Ia and Ib, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed. | 05-12-2011 |
20110172216 | PYRAZOLOPYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE - Compounds of Formula I, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed. | 07-14-2011 |
Shumei Wang, Beijing CN
Patent application number | Description | Published |
---|---|---|
20110275807 | Application of Evodiamine in preparing medicaments for Alzheimer's disease - A method of preparing medicaments for Alzheimer's disease includes the step of administering Evodiamine. Evodiamine can improve the main symptom of Alzheimer's disease, namely, the loss of learning and memory abilities, and delay the progress of Alzheimer's disease. The effects of Evodiamine are represented by following two aspects. Firstly, it can inhibit the over-activation of the microglias in the brain tissue, consistent with the reduction of the over-expression of the cytokines IL-Iβ, IL-6 and TNF-α. Secondly, it can reduce the expression of the cyclaoxygenase-2 thus inhibiting the inflammation in the central nervous system. Researches on curative effects and molecular mechanism of applying Evodiamine to Alzheimer's disease have proved that Evodiamine has a good therapeutic effect and has a potential to develop into a clinical therapy medicament. | 11-10-2011 |
Shumei Zhang, Fushun CN
Patent application number | Description | Published |
---|---|---|
20140275683 | Catalyst for Preparing Isobutene by Dissociation of Methyl Tert-Butyl Ether, Preparation Method and Use Thereof - Disclosed is a catalyst for preparing isobutene by dissociation of methyl tert-butyl ether, the catalyst comprising amorphous silica alumina and a silicalite-1 molecular sieve, wherein the total IR acid amount of weak acids in the catalyst is in a range from 0.020 to 0.080 mmol/g, and the ratio of B acid/L acid of the weak acids is in a range from 2.5:1 to 4.0:1. Also provided is a method of preparing the catalyst and the use thereof. The catalyst has a high selectivity with respect to isobutene, and high conversion of methyl tert-butyl ether, and can also effectively inhibit formation of the by-product dimethyl ether. | 09-18-2014 |